University of Brasilia
Also known as: Brasilia Heart Study Group | Brasilia University | Brasilia University - Brasilia's University Hospital - Geriatric Medical Center | Brasilia University - Brasilia's University Hospital - Geriatric Medical Centre | Brasilia University Hospital | Faculty of Medicine, University of Brasilia | FAMEP | Hospital de Base | Hospital de Base do Distrito Federal | Hospital de Base do Distrito Federal, Brazil | Hospital Oftalmologico de Brasilia | Hospital Universitario de Brasilia | Instituto de Cardiologia do Distrito Federal, Brasilia, Brazil | João Luiz Q. Durigan | Universidade de Brasilia | University Hospital of Brasilia | University of BrasÃlia | University of Brasilia | University of Brasília | University of Brasilia Medical School | University of Brasilia Medical School, Brasilia, Brazil
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2006Last known activity
Jul 15, 2022
Timeline
1960s
- Jan 1, 1962
University of Brasilia— Founded
Drugs by trial phase (47 distinct, 52 trials)
Phase 4 (24 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Alopecia
- Alopecia Areata
- Alzheimer Disease
- Asthma
- Bradycardia
- Cataract
- Cough
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Edema
- Emergence Delirium
- Head and Neck Neoplasms
- Hearing Loss
- Hypersensitivity
- Hypertension
- Hypotension
- Infarction
- Inflammation
- Insulin Resistance
- Joint Diseases
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Leishmaniasis, Mucocutaneous
- Leishmaniasis, Visceral
- Leprosy
- Macular Edema
- Myocardial Infarction
- Onychomycosis
- Parasomnias
- Postoperative Pain
- Psychomotor Agitation
- Pterygium
- Radiodermatitis
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Spondylolisthesis
- Spondylolysis
Recent trials (50)
- NCT05498857Overall official - principal investigatorPhase 4Jul 15, 2022
- NCT05498857Lead sponsorPhase 4Jul 15, 2022
- NCT05498857Reponsible party - principal investigatorPhase 4Jul 15, 2022
- NCT06040489Lead sponsorPhase 2/Phase 3Jun 22, 2022
- NCT04291794Lead sponsorPhase 4Mar 1, 2020
- NCT04291794Reponsible party - principal investigatorPhase 4Mar 1, 2020
- NCT04288466Lead sponsorN/AJan 1, 2020
- NCT04288466Reponsible party - principal investigatorN/AJan 1, 2020
- NCT04264286Reponsible party - principal investigatorPhase 4Jul 1, 2019
- NCT04264286Lead sponsorPhase 4Jul 1, 2019
- NCT04264286Overall official - principal investigatorPhase 4Jul 1, 2019
- NCT03973411Reponsible party - principal investigatorPhase 4Mar 1, 2019
- NCT03973411Lead sponsorPhase 4Mar 1, 2019
- NCT03973411Overall official - principal investigatorPhase 4Mar 1, 2019
- NCT03725228Reponsible party - principal investigatorPhase 4Nov 7, 2018
Details
- Founded
- Brasilia, BR Jan 1, 1962
- Last known activity
- Jul 15, 2022